Genetic variants of SARS CoV2 have been emerging and causing concern to health, political, and economic officials around the world since the onset of the COVID-19 pandemic. The most recent

Dr. Sarah Zaidi, the editor and co-author of “Breaking Down Covid-19,” a comprehensive review of the SARS-CoV-2 virus and pandemic, who has kindly contributed her epidemiology expertise to our clients

With encouraging news breaking over the past few days on the efficacy of the Pfizer and Moderna mRNA based COVID-19 vaccines, Dr. Sarah Zaidi, the epidemiologist who has been kind

A steady drum beat of news reports of potential COVID vaccine and therapeutic treatments has kept investors guessing as to the timing of “the great equity market rotation,” where virus

News overnight that the UK has broadened its quarantine requirements for travelers from European countries with spiking COVID cases is a stark reminder of the ongoing challenges faced by policymakers

Reports over the weekend of a new COVID-19 cluster outbreak in Beijing’s Xinfadi Wholesale Market – the largest agricultural produce market in all of Asia by trading volume – is

Financial markets exploded today on the release of positive results from a small Phase 1 trial of a mRNA type vaccine for COVID-19 that is under development by Moderna. We

We are pleased to share another, brief, report submitted by epidemiologist Dr. Sarah Zaidi exclusively for SGH Macro Advisors titled “COVID-19 and Children”. This piece was researched and written in response

We are pleased to share a report submitted by epidemiologist Dr. Sarah Zaidi exclusively for SGH Macro Advisors titled “COVID-19: Mutations and Transmission Data Points”. In her piece, Dr. Zaidi addresses

We are pleased to share this latest update written by epidemiologist Dr. Sarah Zaidi exclusively for SGH Macro Advisors, titled “COVID-19: Tests, Treatments, and Vaccines”. Dr. Zaidi provides a comprehensive

With markets and the population at large eagerly looking for a light at the end of the COVID-19 pandemic tunnel, we are pleased to share with you the latest exclusive

We are pleased to share with you a comprehensive report put together by Dr. Sarah Zaidi for SGH Macro Advisors in which she reviews the main treatment trials for COVID-19

We are pleased to share with you the latest report produced by Dr. Sarah Zaidi for SGH Macro Advisors on the COVID-19 pandemic — this one titled “Controlling a Second

We are pleased to share with you the latest report produced by Dr. Sarah Zaidi for SGH Macro Advisors on the COVID-19 pandemic — this one titled “Interrupting Transmission Chains.”

Please note: this report reflects the assessment by Beijing’s leadership of the Federal Reserve and European Central Bank actions, potential US fiscal actions, risk points, and the impact of policy decisions and

Dr. Sarah Zaidi has provided an updated analysis of the COVID-19 spread, testing methodologies, and on questions over the potential mutation of the virus. As with our previous COVID-19 reports, this report

Rumors are swirling about a Jerusalem Post article claiming Israeli scientists are “on the cusp” of developing a coronavirus vaccine, one which will be ready within three weeks and available for distribution

On Tuesday, a senior US health official warned that a broader spread of the COVID-19 disease in the United States was a matter of “when,” and not “if,” and painted

Markets have been trying to “look through” the COVID-19 epidemic, taking solace in figures indicating a deceleration in the rate of new outbreaks and deaths from the COVID-19 epidemic that

We are pleased to share the attached PDF report summarizing the latest thinking in the scientific community on the novel coronavirus (2019-nCoV) and COVID disease produced exclusively for SGH Macro